Market Cap | ₹672Cr |
ROE | 14.72% |
P/E Ratio(TTM) | 28.67 |
EPS(TTM) | 49.65 |
P/B Ratio | 4.75 |
Dividend Yield | 0.05% |
Industry P/E | 39.79 |
Book Value | 299.47 |
Debt to Equity | 1.18 |
Face Value | 10 |
Parent Organisation | Fredun Pharmaceuticals Ltd |
Managing Director | Mr. Fredun Medhora |
BSE Symbol | 539730 |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 60.29 | ||
Gland Pharma | NA (0.00%) | 41.84 | ||
Ajanta Pharma | NA (0.00%) | 32.36 | ||
Eris Lifesciences | NA (0.00%) | 53.04 |